BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Telix Pharmaceuticals Spins Off Rhine Pharma to Expand Global Cancer Imaging and Treatment Access

Telix Pharmaceuticals Limited announces the spin-off of Rhine Pharma, a wholly-owned subsidiary with the mission of expanding global access to innovative r...

October 23, 2024 | News

Thermo Fisher’s Oncomine Dx Target Test Receives FDA Approval to Guide Treatment with Servier’s VORANIGO® for Grade 2 IDH-Mutant Glioma

Oncomine Dx Target Test to Identify Patients Eligible for Servier’s VORANIGO® (vorasidenib) tablet, the only FDA-approved treatment for Grade 2 I...

October 22, 2024 | News

Australia's Telix Pharmaceuticals Files for Nasdaq Listing to Expand U.S. Market Access

Telix Pharmaceuticals announces that it has publicly filed a Form 20-F registration statement (Registration Statement) with the United States (U....

October 21, 2024 | News

CSL Vifor and Travere Therapeutics Secure Swissmedic Approval for FILSPARI in Treatment of IgA Nephropathy

CSL Vifor and Travere Therapeutics, announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the treatment of adults w...

October 18, 2024 | News

Isolere Bio by Donaldson Introduces Research-Grade IsoTag™ AAV Reagent for Superior Viral Vector Purification

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of research-grade IsoTag™ AAV reagent, ...

October 18, 2024 | News

Innovent Biologics' Picankibart Achieves Primary Endpoint in Phase 2 Clinical Study for Ulcerative Colitis

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

October 17, 2024 | News

Lenovo Collaborates with Innovations in Dementia to Launch AI-Powered ‘Alzheimer’s Intelligence’ Avatar for Early Dementia Support

Lenovo™ in collaboration with Innovations in Dementia, launched Alzheimer’s Intelligence, a photorealistic 3D avatar with custom AI based ...

October 16, 2024 | News

Endogenex Achieves Key Clinical Milestone with First Patient Enrolled in ReCET™ Study for Type 2 Diabetes Treatment

Achieving a Significant Clinical Milestone in Assessing the ReCET™ System as a Groundbreaking Treatment for Type 2 Diabetes Endogenex, Inc., a clini...

October 16, 2024 | News

BD and Hamilton Collaborate to Streamline Genomic Sequencing with Automation-Ready Reagent Kits

Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing &nb...

October 15, 2024 | News

Leading Drug Discovery CRO NovAliX Partners with Bruker to Transform Therapeutic Innovation

Bruker Acquires Minority Stake in NovAliX in Strategic Move Partnership Leverages Synergies Between Premium Drug Discovery CRO and High-Value Life Scien...

October 11, 2024 | News

CanSinoBIO Secures Over $17 Million Grant to Propel Polio Vaccine Trials in Indonesia and Advance Global Eradication Efforts

CanSino Biologics has announced a milestone in its fight against polio. The company has received an additional financial boost, securing a grant exceeding ...